Dr Anguraj Sadanandam’s Team is investigating methods to classify pancreatic-, colorectal-, breast- and multiple other cancer patients into clinically relevant subgroups.
Dr Sadanandam applies the multidisciplinary experience both in the wet-lab and computational biology to identify and test personalised therapies for different cancer types.